{"id":3972,"date":"2026-10-12T17:50:53","date_gmt":"2026-10-12T17:50:53","guid":{"rendered":"https:\/\/drsoniafawad.com\/?p=3972"},"modified":"2026-10-12T17:50:53","modified_gmt":"2026-10-12T17:50:53","slug":"fertility-treatment-a-viable-option-for-women-with-ibd","status":"publish","type":"post","link":"https:\/\/drsoniafawad.com\/?p=3972","title":{"rendered":"Fertility treatment \u2018a viable option\u2019 for women with IBD"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div data-component=\"ArticleContent\">\n<div class=\"article__below-title\">\n<div class=\" article__posted-date\">\n<p>October 12, 2026<\/p>\n<p>2 min read<\/p>\n<\/p><\/div>\n<div class=\"mobile-trust-box\">\n<div class=\"row\">\n<div class=\"col-12 col-md-5 d-xl-none\">\n<div class=\"trust-box\">\n<div class=\"trust-box-logo d-none d-md-block\">\n            <img decoding=\"async\" src=\"https:\/\/www.healio.com\/~\/media\/h5\/feature\/news\/publogos\/hgld\/healio_gastro.svg?la=en&amp;h=40&amp;w=152&amp;hash=2C654A538F2E250F5183D42A89FE0EC0\" class=\"logo-img\" height=\"40\" alt=\"Healio Logo - Gastroenterology\" width=\"152\"\/>\n          <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"col-12 col-md-6 offset-md-1 offset-xl-0 col-xl-12\">\n<div class=\"email-alert-button-wrapper d-none\" data-component=\"EmailTopicAlert\" data-module=\"Subspecialty Email Topic Alerts Top\" data-manage-email-link=\"\/footer\/account-information\/my-account\/email-subscriptions-and-alerts#emailAlerts\">\n  <hidden data-setting-item=\"d265901d-6d37-49c7-a8f6-c7bf19a02509\"\/><br \/>\n  <hidden data-crm-source=\"Subspecialty Topic Alert\"\/><\/p>\n<div class=\"email-alert-button d-none\" data-topic-button=\"not-subscribed\">\n<p>&#13;<br \/>\n      <span data-module-track-action=\"Email Alerts TOP_Click_Healio News Article\" data-module-track-label=\"Email Alerts TOP_Healio News Article\">&#13;<br \/>\n        <i class=\"fas fa-plus-circle\"\/>&#13;<br \/>\n        Add topic to email alerts&#13;<br \/>\n      <\/span>&#13;\n    <\/p>\n<div class=\"email-alert-inner collapse u26fa5b44c38548118ad8d6d177c55b0c\">\n<div class=\"email-alert-dialogue\">\n<p>&#13;<br \/>\n          Receive an email when new articles are posted on <span data-content=\"topic-title\"\/>&#13;\n        <\/p>\n<div class=\"d-none\" data-sign-up-type=\"unknown\">\n          Please provide your email address to receive an email when new articles are posted on <span data-content=\"topic-title\"\/>.<\/p><\/div>\n<\/p><\/div>\n<p>      <button type=\"button\" class=\"btn btn-primary\" data-loading-text=\"Loading &lt;i class=\" fa=\"\" fa-spinner=\"\" fa-spin=\"\">&#8220;&#13;<br \/>\n              data-action=&#8221;subscribe&#8221;&gt;&#13;<br \/>\n        Subscribe&#13;<br \/>\n      <\/button>\n    <\/div>\n<\/p><\/div>\n<div class=\"d-none\" data-topic-modal=\"failed\">    <strong>We were unable to process your request. Please try again later. If you continue to have this issue please contact <a href=\"https:\/\/www.healio.com\/news\/gastroenterology\/20261012\/mailto:customerservice@slackinc.com\">customerservice@slackinc.com<\/a>.<\/strong>  <\/p>\n<p><button data-dismiss=\"modal\" class=\"btn btn-primary btn-lg btn-block\">Back to Healio<\/button><\/p>\n<\/div>\n<\/div><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<h2>Key takeaways:<\/h2>\n<ul>\n<li>Analysis showed 85% of women with IBD who underwent embryo transfer achieved pregnancy.<\/li>\n<li>Active disease and prior pelvic-related IBD surgery did not appear to affect fertility treatment success.<\/li>\n<\/ul>\n<p>NASHVILLE, Tenn. \u2014 Assisted reproductive technology, particularly IVF, appears to be effective for women with inflammatory bowel disease, including those with prior IBD-related surgery, according to study results.<\/p>\n<p>Findings presented at ACG Annual Scientific Meeting also showed that active disease did not have a significant impact on the <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/womens-health-ob-gyn\/20251031\/qa-how-clinicians-can-help-fight-for-better-ivf-access\" id=\"rId10\" target=\"_blank\">success of fertility treatments<\/a>.<\/p>\n<figure class=\"figure article__og-image\">&#13;\n    <picture>&#13;<source srcset=\"https:\/\/www.healio.comhttps:\/\/www.healio.comhttps:\/\/www.healio.com\/~\/media\/slack-news\/gastroenterology\/misc\/infographics\/2026\/1026\/hgi1026shmidt_acg_podium.webp?w=476\" media=\"(max-width: 768px)\">&#13;<source srcset=\"https:\/\/www.healio.com\/~\/media\/slack-news\/gastroenterology\/misc\/infographics\/2026\/1026\/hgi1026shmidt_acg_podium.webp?w=800\" media=\"(max-width: 992px)\">&#13;<source srcset=\"https:\/\/www.healio.com\/~\/media\/slack-news\/gastroenterology\/misc\/infographics\/2026\/1026\/hgi1026shmidt_acg_podium.webp?w=595\" media=\"(max-width: 1200px)\">&#13;<source srcset=\"https:\/\/www.healio.comhttps:\/\/www.healio.comhttps:\/\/www.healio.com\/~\/media\/slack-news\/gastroenterology\/misc\/infographics\/2026\/1026\/hgi1026shmidt_acg_podium.webp?w=476\" media=\"(min-width: 1200px)\">&#13;<source srcset=\"https:\/\/www.healio.comhttps:\/\/www.healio.comhttps:\/\/www.healio.com\/~\/media\/slack-news\/gastroenterology\/misc\/infographics\/2026\/1026\/hgi1026shmidt_acg_podium.webp?w=476\">&#13;<br \/>\n&#13;<br \/>\n      <img decoding=\"async\" src=\"https:\/\/www.healio.com\/~\/media\/slack-news\/gastroenterology\/misc\/infographics\/2026\/1026\/hgi1026shmidt_acg_podium.jpg?w=800\" alt=\"Eugenia Shmidt, MD, FACG, FCCF podium shot\" class=\"figure-img img-fluid\" width=\"800\"\/>&#13;<br \/>\n    <\/source><\/source><\/source><\/source><\/source><\/picture>&#13;<figcaption class=\"figure-caption\">&#13;<br \/>\n      Eugenia Scmidt, MD, FACG, FCCF, presents data from the podium at ACG Annual Scientific Meeting.\u00a0<em>Photo: Heather Biele.<\/em><\/figcaption>&#13;<br \/>\n  <\/figure>\n<p>\u201cWe know that women with IBD face unique reproductive challenges,\u201d <b>Eugenia Shmidt, MD, FACG, FCCF,<\/b> founder of the IBD Preconception and Pregnancy Planning Clinic at University of Minnesota, told Healio. \u201cSome women with IBD have reduced fertility. We know that fertility treatments can help overcome this challenge.\u201d<\/p>\n<p>Although guidelines have shown assisted reproductive technology to be equally effective among women with and without IBD, little is known about its use and predictors of success among <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/gastroenterology\/20261007\/healthy-lifestyle-in-early-childhood-linked-to-lower-risk-for-ibd-particularly-crohns\" id=\"rId11\" target=\"_blank\">those with IBD<\/a>.<\/p>\n<p>Shmidt and colleagues analyzed prospective data from the Women with Inflammatory Bowel Disease &amp; Motherhood (WIsDoM) study, which includes women aged 18 to 45 years with IBD attempting pregnancy within 15 months.<\/p>\n<p>Achieving pregnancy after fertility treatment served as the primary outcome. Secondary outcomes included associations between treatment success, disease activity and previous IBD-related surgery.<\/p>\n<p>Analysis included 421 women, of whom 67 underwent fertility treatments. Thirteen underwent only intrauterine insemination (IUI), and 39 underwent embryo transfer, with or without IUI.<\/p>\n<p>Women who underwent fertility treatment were significantly more likely to be older than those who did not undergo treatment (34 vs. 32 years; <i>P<\/i> &lt; .001). They also were more likely to have received prior fertility treatment (31.3% vs. 8.8%; <i>P<\/i> &lt;.001), attempted conception longer (11 vs. 2 months; <i>P<\/i> &lt; .001) and have active disease at the time of treatment (56.7% vs. 43.5%).<\/p>\n<p>Prior pelvic IBD surgery was more common in this group, as well (16.4% vs. 5.4%; <i>P<\/i> = .01).<\/p>\n<p>Overall, there were 97 pregnancy attempts (IUI, n = 49; embryo transfer, n = 48). Repeated treatments were common, with 42% of women requiring multiple attempts (IUI cycles: mean, 2.45; embryo transfers: mean, 1.23).<\/p>\n<p>Outcomes were \u201chighly encouraging,\u201d Shmidt told attendees, noting that 73% of women achieved pregnancy with fertility treatment. However, she emphasized that success \u201cvaried dramatically\u201d by modality.<\/p>\n<p>Among women undergoing only IUI, 38% achieved pregnancy, whereas 85% of women undergoing embryo transfer, with or without prior IUI, conceived.<\/p>\n<p>\u201cMost strikingly, among nine women with prior IBD-related pelvic surgery, all of those who underwent embryo transfer conceived, whereas none who attempted IUI alone became pregnant,\u201d Shmidt said.<\/p>\n<p>Multivariable analysis also showed significantly higher odds of achieving pregnancy with embryo transfer vs. IUI (adjusted OR = 44; 95% CI, 8.9-221).<\/p>\n<p>\u201cThe most intriguing finding was the difference between IUI and IVF success rates,\u201d Shmidt told Healio. \u201cWe found that controlling for prior treatment cycles and other factors, patients demonstrated a 44-fold increase in pregnancy odds when undergoing IVF compared to IUI.\u201d<\/p>\n<p>Pregnancy success remained higher with embryo transfer, regardless of prior IUI (OR = 0.83; 95% CI, 0.17-4.1).<\/p>\n<p>The researchers observed no associations between treatment success and prior IBD surgery, pelvic-specific IBD surgery or active disease when undergoing fertility treatment.<\/p>\n<p>\u201cWe hope that our findings equip clinicians with the knowledge that fertility treatments can be a viable option for <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/gastroenterology\/20240424\/family-planning-in-ibd-it-is-our-responsibility-to-share-accurate-resources-support\" id=\"rId12\" target=\"_blank\">women with IBD<\/a> who are interested in motherhood,\u201d Shmidt told Healio.<\/p>\n<h2>For more information:<\/h2>\n<p>      <b>Eugenia Shmidt<\/b><b>, MD, <\/b><b>FACG, FCCF<\/b><b>,<\/b><b> <\/b>is associate professor in the division of gastroenterology, hepatology and nutrition and codirector of the IBD program at University of Minnesota. She can be reached at<b> <\/b>      <a rel=\"noopener noreferrer\" href=\"https:\/\/www.healio.com\/news\/gastroenterology\/20261012\/mailto:gastroenterology@healio.com\" id=\"rId13\" target=\"_blank\">gastroenterology@healio.com<\/a><b>.<\/b><\/p>\n<div class=\"article__content--footer\">\n<div class=\"publisher-logo\">\n    <span>Published by:<\/span><br \/>\n    <img decoding=\"async\" src=\"https:\/\/www.healio.com\/~\/media\/h5\/feature\/news\/publogos\/hgld\/healio_gastro.svg?la=en&amp;h=40&amp;w=152&amp;hash=2C654A538F2E250F5183D42A89FE0EC0\" class=\"logo-img\" height=\"40\" alt=\"Healio Logo - Gastroenterology\" width=\"152\"\/>\n  <\/div>\n<div class=\"sources-references-disclosures\">\n<h3>Sources\/Disclosures<\/h3>\n<h2> Source: <\/h2>\n<p class=\"citation\">Shmidt E, et al. Assisted reproductive technology outcomes in women with inflammatory bowel disease: Prospective data from the WIsDoM cohort. Presented at: ACG Annual Scientific Meeting; Oct. 12-14, 2026; Nashville, Tenn. (hybrid meeting).<\/p>\n<div class=\"disclosures\">\n<p>&#13;<br \/>\n        <strong> Disclosures: <\/strong>&#13;<br \/>\n        Shmidt reports advisory committee\/board member roles with Johnson &amp; Johnson. Please see the study for all other authors\u2019 relevant financial disclosures.&#13;\n      <\/p>\n<\/p><\/div>\n<\/div>\n<p><!-- Healio AI Widget --><\/p>\n<div class=\"healio-ai-component-inline\" data-no-ads=\"true\" data-module-track-category=\"Healio AI\" data-module-track-action=\"Click\" data-module-track-label=\"Access Healio Ai from component - News_AI Component - In-Content (all devices)\">\n<div class=\"healio-ai-content\">\n    <img decoding=\"async\" src=\"https:\/\/m3.healio.com\/~\/media\/images\/healio-ai\/healio-ai_logo.svg\" alt=\"Healio AI\" class=\"healio-ai-logo\"\/><\/p>\n<p><strong>Ask a clinical question<\/strong> and tap into <strong>Healio AI&#8217;s knowledge<\/strong> base.<\/p>\n<ul>&#13;<\/p>\n<li>PubMed, enrolling\/recruiting trials, guidelines<\/li>\n<p>&#13;<\/p>\n<li>Clinical Guidance, Healio CME, FDA news<\/li>\n<p>&#13;<\/p>\n<li>Healio&#8217;s exclusive daily news coverage of clinical data<\/li>\n<p>&#13;\n    <\/ul>\n<p>    <button class=\"healio-ai-button\" onclick=\"window.location.href=\" https:=\"\">Learn more<\/button>\n  <\/div>\n<\/div>\n<div class=\"email-alert-button-wrapper d-none\" data-component=\"EmailTopicAlert\" data-module=\"Subspecialty Email Topic Alerts Top\" data-manage-email-link=\"\/footer\/account-information\/my-account\/email-subscriptions-and-alerts#emailAlerts\">\n  <hidden data-setting-item=\"d265901d-6d37-49c7-a8f6-c7bf19a02509\"\/><br \/>\n  <hidden data-crm-source=\"Subspecialty Topic Alert\"\/><\/p>\n<div class=\"email-alert-button d-none\" data-topic-button=\"not-subscribed\">\n<p>&#13;<br \/>\n      <span data-module-track-action=\"Email Alerts TOP_Click_Healio News Article\" data-module-track-label=\"Email Alerts TOP_Healio News Article\">&#13;<br \/>\n        <i class=\"fas fa-plus-circle\"\/>&#13;<br \/>\n        Add topic to email alerts&#13;<br \/>\n      <\/span>&#13;\n    <\/p>\n<div class=\"email-alert-inner collapse u26fa5b44c38548118ad8d6d177c55b0c\">\n<div class=\"email-alert-dialogue\">\n<p>&#13;<br \/>\n          Receive an email when new articles are posted on <span data-content=\"topic-title\"\/>&#13;\n        <\/p>\n<div class=\"d-none\" data-sign-up-type=\"unknown\">\n          Please provide your email address to receive an email when new articles are posted on <span data-content=\"topic-title\"\/>.<\/p><\/div>\n<\/p><\/div>\n<p>      <button type=\"button\" class=\"btn btn-primary\" data-loading-text=\"Loading &lt;i class=\" fa=\"\" fa-spinner=\"\" fa-spin=\"\">&#8220;&#13;<br \/>\n              data-action=&#8221;subscribe&#8221;&gt;&#13;<br \/>\n        Subscribe&#13;<br \/>\n      <\/button>\n    <\/div>\n<\/p><\/div>\n<div class=\"d-none\" data-topic-modal=\"failed\">    <strong>We were unable to process your request. Please try again later. If you continue to have this issue please contact <a href=\"https:\/\/www.healio.com\/news\/gastroenterology\/20261012\/mailto:customerservice@slackinc.com\">customerservice@slackinc.com<\/a>.<\/strong>  <\/p>\n<p><button data-dismiss=\"modal\" class=\"btn btn-primary btn-lg btn-block\">Back to Healio<\/button><\/p>\n<\/div>\n<\/div><\/div>\n<\/p><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.healio.com\/news\/gastroenterology\/20261012\/fertility-treatment-a-viable-option-for-women-with-ibd-regardless-of-prior-surgery\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>October 12, 2026 2 min read &#13; &#13; &#13; Add topic to email alerts&#13; &#13; &#13; Receive an email when new articles are posted on &#13; Please provide your email address to receive an email when new articles are posted on . &#8220;&#13; data-action=&#8221;subscribe&#8221;&gt;&#13; Subscribe&#13; We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: Analysis showed 85% of women with IBD who underwent embryo transfer achieved pregnancy. Active disease and prior pelvic-related IBD surgery did not appear to affect fertility treatment success. NASHVILLE, Tenn. \u2014 Assisted reproductive technology, particularly IVF, appears to be effective for women with inflammatory bowel disease, including those with prior IBD-related surgery, according to study results. Findings presented at ACG Annual Scientific Meeting also showed that active disease did not have a significant impact on the success of fertility treatments. &#13; &#13;&#13;&#13;&#13;&#13;&#13; &#13; &#13; &#13;&#13; Eugenia Scmidt, MD, FACG, FCCF, presents data from the podium at ACG Annual Scientific Meeting.\u00a0Photo: Heather Biele.&#13; \u201cWe know that women with IBD face unique reproductive challenges,\u201d Eugenia Shmidt, MD, FACG, FCCF, founder of the IBD Preconception and Pregnancy Planning Clinic at University of Minnesota, told Healio. \u201cSome women with IBD have reduced fertility. We know that fertility treatments can help overcome this challenge.\u201d Although guidelines have shown assisted reproductive technology to be equally effective among women with and without IBD, little is known about its use and predictors of success among those with IBD. Shmidt and colleagues analyzed prospective data from the Women with Inflammatory Bowel Disease &amp; Motherhood (WIsDoM) study, which includes women aged 18 to 45 years with IBD attempting pregnancy within 15 months. Achieving pregnancy after fertility treatment served as the primary outcome. Secondary outcomes included associations between treatment success, disease activity and previous IBD-related surgery. Analysis included 421 women, of whom 67 underwent fertility treatments. Thirteen underwent only intrauterine insemination (IUI), and 39 underwent embryo transfer, with or without IUI. Women who underwent fertility treatment were significantly more likely to be older than those who did not undergo treatment (34 vs. 32 years; P &lt; .001). They also were more likely to have received prior fertility treatment (31.3% vs. 8.8%; P &lt;.001), attempted conception longer (11 vs. 2 months; P &lt; .001) and have active disease at the time of treatment (56.7% vs. 43.5%). Prior pelvic IBD surgery was more common in this group, as well (16.4% vs. 5.4%; P = .01). Overall, there were 97 pregnancy attempts (IUI, n = 49; embryo transfer, n = 48). Repeated treatments were common, with 42% of women requiring multiple attempts (IUI cycles: mean, 2.45; embryo transfers: mean, 1.23). Outcomes were \u201chighly encouraging,\u201d Shmidt told attendees, noting that 73% of women achieved pregnancy with fertility treatment. However, she emphasized that success \u201cvaried dramatically\u201d by modality. Among women undergoing only IUI, 38% achieved pregnancy, whereas 85% of women undergoing embryo transfer, with or without prior IUI, conceived. \u201cMost strikingly, among nine women with prior IBD-related pelvic surgery, all of those who underwent embryo transfer conceived, whereas none who attempted IUI alone became pregnant,\u201d Shmidt said. Multivariable analysis also showed significantly higher odds of achieving pregnancy with embryo transfer vs. IUI (adjusted OR = 44; 95% CI, 8.9-221). \u201cThe most intriguing finding was the difference between IUI and IVF success rates,\u201d Shmidt told Healio. \u201cWe found that controlling for prior treatment cycles and other factors, patients demonstrated a 44-fold increase in pregnancy odds when undergoing IVF compared to IUI.\u201d Pregnancy success remained higher with embryo transfer, regardless of prior IUI (OR = 0.83; 95% CI, 0.17-4.1). The researchers observed no associations between treatment success and prior IBD surgery, pelvic-specific IBD surgery or active disease when undergoing fertility treatment. \u201cWe hope that our findings equip clinicians with the knowledge that fertility treatments can be a viable option for women with IBD who are interested in motherhood,\u201d Shmidt told Healio. For more information: Eugenia Shmidt, MD, FACG, FCCF, is associate professor in the division of gastroenterology, hepatology and nutrition and codirector of the IBD program at University of Minnesota. She can be reached at gastroenterology@healio.com. Published by: Sources\/Disclosures Source: Shmidt E, et al. Assisted reproductive technology outcomes in women with inflammatory bowel disease: Prospective data from the WIsDoM cohort. Presented at: ACG Annual Scientific Meeting; Oct. 12-14, 2026; Nashville, Tenn. (hybrid meeting). &#13; Disclosures: &#13; Shmidt reports advisory committee\/board member roles with Johnson &amp; Johnson. Please see the study for all other authors\u2019 relevant financial disclosures.&#13; Ask a clinical question and tap into Healio AI&#8217;s knowledge base. &#13; PubMed, enrolling\/recruiting trials, guidelines &#13; Clinical Guidance, Healio CME, FDA news &#13; Healio&#8217;s exclusive daily news coverage of clinical data &#13; Learn more &#13; &#13; &#13; Add topic to email alerts&#13; &#13; &#13; Receive an email when new articles are posted on &#13; Please provide your email address to receive an email when new articles are posted on . &#8220;&#13; data-action=&#8221;subscribe&#8221;&gt;&#13; Subscribe&#13; We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Source link<\/p>\n","protected":false},"author":1,"featured_media":3973,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3972","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts\/3972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3972"}],"version-history":[{"count":0,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts\/3972\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/media\/3973"}],"wp:attachment":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}